Jefferies Financial Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.35M Buy
35,629
+16,750
+89% +$1.82M 0.04% 373
2026
Q1
$1.74M Sell
18,879
-45,039
-70% -$4.52M 0.01% 685
2025
Q4
$6.53M Sell
63,918
-5,981
-9% -$535K 0.03% 429
2025
Q3
$4.37M Buy
69,899
+67,796
+3,224% +$3.69M 0.02% 401
2025
Q2
$109K Buy
+2,103
New +$93.9K ﹤0.01% 1170
2024
Q4
Sell
-300
Closed -$6.88K 1675
2024
Q3
$6.88K Buy
+300
New +$8.49K ﹤0.01% 1393

Other funds holding GH

Jefferies Financial Group's GH Position: Q2 2026 in Review

Jefferies Financial Group increased its Guardant Health (GH) stake by 89% in Q2 2026, buying an estimated $1.82M and bringing the position to 35,629 shares worth $5.35M. The position accounts for 0.04% of the portfolio, ranked #373.

Jefferies Financial Group first reported a position in GH in Q3 2024 and has held it in 6 quarters since. The position peaked at $6.53M in Q4 2025. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Jefferies Financial Group held 35,629 shares of Guardant Health worth $5.35M as of Q2 2026.
  • Jefferies Financial Group bought 16,750 Guardant Health shares in Q2 2026, an estimated $1.82M.
  • Guardant Health made up 0.04% of Jefferies Financial Group's portfolio in Q2 2026, its #373 holding.
  • Jefferies Financial Group first reported a position in Guardant Health in Q3 2024 and has held it in 6 quarters since.
  • Jefferies Financial Group's Guardant Health position peaked at $6.53M in Q4 2025.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.